Biomarkers: Promising and valuable tools towards diagnosis, prognosis and treatment of Covid-19 and other diseases


Ali Bodaghi,a Nadia Fattahi,b,c and Ali Ramazanib,d,∗ Heliyon. 2023 Feb; 9(2): e13323. Published online 2023 Jan 30. doi: 10.1016/j.heliyon.2023.e13323 PMCID: PMC9884646 PMID: 36744065 The use of biomarkers as early warning systems in the evaluation of disease risk has increased markedly in the last decade. Biomarkers are indicators of typical biological processes, pathogenic processes, or pharmacological reactions to therapy. The application and identification of biomarkers […]

Auditory Disturbances and SARS-CoV-2 Infection: Brain Inflammation or Cochlear Affection? Systematic Review and Discussion of Potential Pathogenesis


Pietro De Luca1, Alfonso Scarpa1, Massimo Ralli2, Domenico Tassone3, Matteo Simone3, Luca De Campora3, Claudia Cassandro4† and Arianna Di Stadio Frontiers in Medicine Patients affected by COVID-19 present a series of different symptoms; despite some of these are common, other less likely appear. Auditory symptoms seem to be less frequent, maybe because rarer or, alternatively, because they are underestimated during the clinical investigation. […]

Researchers are working together to better understand and treat the syndrome


Authors:  SABRINA RICHARDS / FRED HUTCH NEWS SERVICE JANUARY 26, 2022 Robin Macnofsky’s first symptoms, in April 2020, were so mild she didn’t take a test for COVID-19, preferring to save it for someone who really needed it. A few weeks later her chest tightened and her temperature spiked. These ebbed, but an even stronger wave […]

Prognostic value of serum/plasma neurofilament light chain for COVID-19-associated mortality


Authors: Ruturaj R. Masvekar,Peter Kosa,Kimberly Jin,Kerry Dobbs,Michael A. Stack,Riccardo Castagnoli,Virginia Quaresima,Helen C. Su,Luisa Imberti,Luigi D. Notarangelo,Bibiana Bielekova 21 March 2022 Annals of Clinical and Translational Neurology Volume 9, Issue 5 p. 622-632 Abstract Objective Given the continued spread of coronavirus 2, the early predictors of coronavirus disease 19 (COVID-19) associated mortality might improve patients’ outcomes. Increased […]

Laboratory Biomarkers for Diagnosis and Prognosis in COVID-19


Authors: Denise Battaglini, 1 , 2 , 3 Miquéias Lopes-Pacheco, 4 Hugo C. Castro-Faria-Neto, 5 Paolo Pelosi, 1 , 2 and Patricia R. M. Rocco 4 , 6 , 7 , * Front Immunol. 2022; 13: 857573.  Apr 27.  2022 doi: 10.3389/fimmu.2022.857573 PMCID: PMC9091347 PMID: 35572561 Abstract Severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) causes a wide spectrum of clinical manifestations, with progression to multiorgan failure in the most severe cases. Several biomarkers can be altered […]